Pelthos Therapeutics (PTHS) Payables (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Payables of $3.0 million for Q4 2025, up 57.41% year-over-year from $1.9 million in Q4 2024, and down 47.3% quarter-over-quarter from $5.7 million in Q3 2025.
Pelthos Therapeutics (PTHS) Payables (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Payables history runs 4 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- In Q4 2025, Payables rose 57.41% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (up 57.41% YoY), while the FY2025 annual figure was $3.0 million, up 57.41% from the prior year.
- Payables for Q4 2025 stood at $3.0 million, down from $5.7 million in the prior quarter.
- The five-year high for Payables was $5.7 million in Q3 2025, with the low at $895.0 in Q2 2024.
- The 4-year median for Payables is $2.7 million (2024), against an average of $2.7 million.
- Peak annual rise in Payables reached 557310.28% in 2025, while the deepest fall reached 99.73% in 2025.
- Pelthos Therapeutics' Payables stood at $3.0 million in 2022, then surged by 54.34% to $4.6 million in 2023, then plunged by 58.95% to $1.9 million in 2024, then soared by 57.41% to $3.0 million in 2025.
- Business Quant data shows PTHS's Payables at $3.0 million in Q4 2025, $5.7 million in Q3 2025, and $5.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Pelthos Therapeutics | 96.56 Mn | 72.00 Mn | 21.23 Mn | 5.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.85 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 5.67 Mn |
| Jun 30, 2025 | 4.99 Mn |
| Mar 31, 2025 | 6,472.00 |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 895.00 |
| Mar 31, 2024 | 2.41 Mn |
| Dec 31, 2023 | 4.62 Mn |
| Dec 31, 2022 | 2.99 Mn |